Warby Parker Inc.
WRBYHealthcareNASDAQMedical Instruments & Supplies · Last scanned Oct 24, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Warby Parker Inc. focuses on Medical Instruments & Supplies services and products. Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. Valued at $3.20B, WRBY is a mid-cap name in its sector. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses.
Market Cap
$3.20B
Beta
1.90
P/E (TTM)
431.83
P/E (Fwd)
42.15
EPS (TTM)
$0.06
EPS (Fwd)
$0.61
ROE
2.1%
ROA
-1.0%
Cash
$292.7M
Total Debt
$251.0M
Free CF
$9.5M
52W Change
21.9%
Annual Financials
Cash vs Debt
Where WRBY stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, WRBY finished 0.87% below its 150-day moving average ($25.21) and 0.95% below its 200-day moving average ($25.23). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is WRBY overbought or oversold?
At the October 20, 2026 close, WRBY's RSI(14) was 37.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Warby Parker Inc. holds $292.7M in cash against $251.0M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $9.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 2.1%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $598.1M (2022) to $871.9M (2025), reflecting a 46% increase over the period.
A beta of 1.90 means WRBY is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Warby Parker Inc.'s trajectory.